IFN GAMMA--ROLES IN DEMYELINATION AND AUTOIMMUNITY
IFN GAMMA--ROLES IN DEMYELINATION AND AUTOIMMUNITY
批准号:
6093055
负责人:
CLAIRE Frances EVANS
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2002-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Interferon-gamma (IFN-gamma) is a cytokine produced in
response to some microbial infections, that has widespread effects
throughout the body. It influences the development and differentiation of
cells involved in immune responses and regulates the expression of
activation, adhesion, and major histocompatibility (MHC) molecules on many
cell types. Several studies have implicated IFN-gamma in the pathology of
central nervous system (CNS) demyelinating diseases, such as multiple
sclerosis (MS). To address the effects of persistent expression of
IFN-gamma in selected regions of the CNS, Dr Evans generated transgenic mice
that express murine IFN-gamma in oligodendrocytes in the CNS. Expression of
the transgene began after eight weeks of age, and resulted in primary axonal
demyelination throughout the CNS accompanied by weight loss, weakness, and
premature death. Dr Evans' results demonstrated that IFN-gamma can induce
CNS demyelination leading to clinical disease. This proposal addresses the
mechanisms by which IFN-gamma induces CNS demyelination, and the effects of
constitutive CNS expression of IFN-gamma on models of CNS autoimmune
disease. The first Specific Aim tests the hypothesis that IFN-gamma-induced
demyelination occurs indirectly by influencing the expression of other
cytokine and/or MHC gene expression in the CNS. The second Aim tests the
hypothesis that expression of IFN-gamma in the CNS induces the synthesis of
nitric oxide, which is toxic to myelin.
The third Aim addresses the hypothesis that the expression of IFN-gamma in
the CNS leads to increased susceptibility to autoimmune disease in the CNS.
The effect of IFN-gamma on the course of two experimentally-induced
autoimmune diseases will be evaluated. The long-term objectives of this
application are to define the roles of IFN-gamma in CNS demyelination and
autoimmunity. The ultimate goals are an understanding of the mechanism of
demyelination in MS, and the design of therapies to treat and prevent this
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Therapeutic DNA Epitope Vaccine for Alzheimer's Disease
-
批准号:8133351
-
项目类别:
-
资助金额:$110.99万
-
财政年份:2009
-
负责人:CLAIRE Frances EVANS
-
依托单位:
A Therapeutic DNA Epitope Vaccine for Alzheimer's Disease
-
批准号:8327266
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:CLAIRE Frances EVANS
-
依托单位:
A Therapeutic DNA Epitope Vaccine for Alzheimer's Disease
-
批准号:7888258
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2009
-
负责人:CLAIRE Frances EVANS
-
依托单位:
A Therapeutic DNA Epitope Vaccine for Alzheimer's Disease
-
批准号:7671172
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2009
-
负责人:CLAIRE Frances EVANS
-
依托单位:
Electroporation-mediated Gene-based Interferon-beta
-
批准号:7154249
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2006
-
负责人:CLAIRE Frances EVANS
-
依托单位:
Development of a DNA Vaccine for Chronic HBV Infection
-
批准号:7197356
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2006
-
负责人:CLAIRE Frances EVANS
-
依托单位:
Hypoxia-modulation of EPO pDNA in Electroporated Muscle
-
批准号:6694505
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2003
-
负责人:CLAIRE Frances EVANS
-
依托单位:
Electroporation-Mediated Gene Therapy with IFN-b for MS
-
批准号:6950267
-
项目类别:
-
资助金额:$70.39万
-
财政年份:2002
-
负责人:CLAIRE Frances EVANS
-
依托单位:
Electroporation-Mediated Gene Therapy with IFN-b for MS
-
批准号:6832697
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2002
-
负责人:CLAIRE Frances EVANS
-
依托单位:
IFN GAMMA--ROLES IN DEMYELINATION AND AUTOIMMUNITY
-
批准号:2456525
-
项目类别:
-
资助金额:$11.36万
-
财政年份:1998
-
负责人:CLAIRE Frances EVANS
-
依托单位:
IFN GAMMA--ROLES IN DEMYELINATION AND AUTOIMMUNITY
-
批准号:2858223
-
项目类别:
-
资助金额:$11.82万
-
财政年份:1998
-
负责人:CLAIRE Frances EVANS
-
依托单位:
IFN GAMMA--ROLES IN DEMYELINATION AND AUTOIMMUNITY
-
批准号:6139553
-
项目类别:
-
资助金额:$12.29万
-
财政年份:1998
-
负责人:CLAIRE Frances EVANS
-
依托单位:
海外基金